257 related articles for article (PubMed ID: 20038519)
1. B-cell anergy is maintained in anti-DNA transgenic NZB/NZW mice.
Kat I; Makdasi E; Fischel R; Eilat D
Int Immunol; 2010 Feb; 22(2):101-11. PubMed ID: 20038519
[TBL] [Abstract][Full Text] [Related]
2. Autoreactive anti-DNA transgenic B cells in lupus-prone New Zealand black/New Zealand white mice show near perfect L chain allelic exclusion.
Makdasi E; Fischel R; Kat I; Eilat D
J Immunol; 2009 May; 182(10):6143-8. PubMed ID: 19414767
[TBL] [Abstract][Full Text] [Related]
3. Autoimmunity develops in lupus-prone NZB mice despite normal T cell tolerance.
Wither J; Vukusic B
J Immunol; 1998 Nov; 161(9):4555-62. PubMed ID: 9794382
[TBL] [Abstract][Full Text] [Related]
4. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune NZB/NZW F1 mice utilize B cell receptor editing for generating high-affinity anti-dsDNA autoantibodies from low-affinity precursors.
Yachimovich-Cohen N; Fischel R; Bachar N; Yarkoni Y; Eilat D
Eur J Immunol; 2003 Sep; 33(9):2469-78. PubMed ID: 12938223
[TBL] [Abstract][Full Text] [Related]
6. B cells are anergic in transgenic mice that express IgM anti-DNA antibodies.
Tsao BP; Chow A; Cheroutre H; Song YW; McGrath ME; Kronenberg M
Eur J Immunol; 1993 Sep; 23(9):2332-9. PubMed ID: 8370409
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.
Yu P; Wellmann U; Kunder S; Quintanilla-Martinez L; Jennen L; Dear N; Amann K; Bauer S; Winkler TH; Wagner H
Int Immunol; 2006 Aug; 18(8):1211-9. PubMed ID: 16798839
[TBL] [Abstract][Full Text] [Related]
8. An intrinsic B-cell defect supports autoimmunity in New Zealand black chromosome 13 congenic mice.
Loh C; Pau E; Chang NH; Wither JE
Eur J Immunol; 2011 Feb; 41(2):527-36. PubMed ID: 21268021
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression.
Wu HY; Monsonego A; Weiner HL
J Autoimmun; 2006 Mar; 26(2):116-26. PubMed ID: 16426816
[TBL] [Abstract][Full Text] [Related]
10. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
Merino R; Iwamoto M; Fossati L; Izui S
J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
[TBL] [Abstract][Full Text] [Related]
11. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
[TBL] [Abstract][Full Text] [Related]
12. Altered toll-like receptor responsiveness underlies a dominant heritable defect in B cell tolerance in autoimmune New Zealand Black mice.
Clark AG; Buckley ES; Foster MH
Eur J Immunol; 2018 Mar; 48(3):492-497. PubMed ID: 29251774
[TBL] [Abstract][Full Text] [Related]
13. Blockade of TLR9 signaling in B cells impaired anti-dsDNA antibody production in mice induced by activated syngenic lymphocyte-derived DNA immunization.
Chen M; Zhang W; Xu W; Zhang F; Xiong S
Mol Immunol; 2011 Jul; 48(12-13):1532-9. PubMed ID: 21592581
[TBL] [Abstract][Full Text] [Related]
14. Raloxifene modulates estrogen-mediated B cell autoreactivity in NZB/W F1 mice.
Zhang Y; Saha S; Rosenfeld G; Gonzalez J; Pepeljugoski KP; Peeva E
J Rheumatol; 2010 Aug; 37(8):1646-57. PubMed ID: 20551107
[TBL] [Abstract][Full Text] [Related]
15. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
16. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
[TBL] [Abstract][Full Text] [Related]
17. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
Brummel R; Roberts TL; Stacey KJ; Lenert P
Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
[TBL] [Abstract][Full Text] [Related]
18. Studies on the structure, regulation, and pathogenic potential of anti-dsDNA antibodies.
Spatz L; Iliev A; Saenko V; Jones L; Irigoyen M; Manheimer-Lory A; Gaynor B; Putterman C; Bynoe M; Kowal C; Kuo P; Newman J; Diamond B
Methods; 1997 Jan; 11(1):70-8. PubMed ID: 8990091
[TBL] [Abstract][Full Text] [Related]
19. Identification of anergic B cells within a wild-type repertoire.
Merrell KT; Benschop RJ; Gauld SB; Aviszus K; Decote-Ricardo D; Wysocki LJ; Cambier JC
Immunity; 2006 Dec; 25(6):953-62. PubMed ID: 17174121
[TBL] [Abstract][Full Text] [Related]
20. Regulation of B cell tolerance by the lupus susceptibility gene Ly108.
Kumar KR; Li L; Yan M; Bhaskarabhatla M; Mobley AB; Nguyen C; Mooney JM; Schatzle JD; Wakeland EK; Mohan C
Science; 2006 Jun; 312(5780):1665-9. PubMed ID: 16778059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
